Skip to main content
FinSpry Logo
FinSpry
KURE logo
KURE
(NYSEARCA)
KraneShares MSCI All China Health Care Index ETF
$18.03-- (--)
Loading... - Market loading
OverviewHoldingsDividendsHistorical

KURE ETF: KraneShares MSCI All China Health Care Index ETF - Price, Holdings & Analysis

KraneShares MSCI All China Health Care Index ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$17.65 - $18.06
52-Week High$21.88
52-Week Low$13.23
Open$17.84
Volume4.56K
Average Volume (3M)4.56K
Assets (AUM)81.66M
Expense Ratio0.65%
Total Holdings49
Inception DateJan 31, 2018
1 Day Change4.42%
1 Month Change2.80%
6 Month Change-16.90%
YTD Change2.50%
1 Year Change11.55%
52-Week Change11.41%
5 Year Change-54.66%
50-Day MA$17.49
200-Day MA$18.75
RSI60.80
Stochastic %K94.20
Stochastic %D62.22
Annual Dividend$0.72
Dividend Yield4.01%
Last Dividend Ex-DateDec 23, 2026
Dividend Growth YoY288.59%
Years Dividend Growth3

Frequently Asked Questions About KraneShares MSCI All China Health Care Index ETF

What is the current price of KURE?

The latest KURE price is $18.03. The 52-week range is $13.23–$21.88. KURE has returned 11.4% over the past 52 weeks.

What is the expense ratio for KURE?

KURE's annual expense ratio is 0.65%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equitys in the ETF Screener.

Does KURE pay dividends?

Yes, KURE pays a 4.01% dividend yield. The last ex-dividend date was 2026-12-23. View full dividend history in the Dividends section.

What are the top holdings of KURE?

KURE's largest holdings are Innovent Biologics, Inc. (8.8%), BeOne Medicines AG (8.3%), WuXi Biologics (8.0%) (combined weight: 25.2%). The fund holds 49 total positions. View the complete portfolio breakdown in the Holdings section.

How does KURE compare to similar ETFs?

Compare KURE (0.65% expense ratio, $82M AUM) against similar Equitys using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.